MedPath

Exercise in Hypoxia and Nitrate Supplementation in Athletes: is the Whole Greater Than the Sum of Its Parts?

Not Applicable
Completed
Conditions
Hypoxia
Registration Number
NCT06727656
Lead Sponsor
University of Trás-os-Montes and Alto Douro
Brief Summary

Determine the combined effect of training in hypoxia and nitrate supplementation on the performance and health of athletes at sea-level and altitude conditions.

Detailed Description

Determine the combined effect of training in hypoxia and nitrate supplementation on the performance and health of athletes at sea-level and altitude conditions. It is hypothesized that the combined effect of these interventions will promote an additional performance and health improvement in this population at sea-level and altitude conditions, compared with the single effect.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • trained male subjects, regularly involved in competitive running, cycling and/ or triathlon events (4-5 times per week) in the past five years
Exclusion Criteria
  • smoking or other chronic issues
  • using medication or dietary supplements in the last 3 months, or during the duration of the study
  • being exposed to altitude (≥2000 m) in the last 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Performance adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

VO2 kinetics (time constant and amplitude of fast and slow oxygen components)

Cardiovascular and neuromuscular adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

Muscular oxygen saturation (SmO2)

Skeletal muscle adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

Mitochondrial and capillary density, capillary-to-fibre ratio and fibre cross-section area - cryosections cut with a cryostat and further samples analysed by fluorescence microscopy

Haematological adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

Plasma \[NO2-\] and \[NO3-\], erythropoietin (EPO), haemoglobin (Hb) and haematocrit (Hct) - all assays on plasma sample analysed by spectrophometry

Oxidative stress and antioxidant markers adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)

Nitrotyrosine, malondialdehyde, ferric-reducing antioxidant power and superoxide dismutase concentrations - all assays on plasma sample analysed by spectrophometry

Secondary Outcome Measures
NameTimeMethod
Sleep and cardiac autonomic activity adaptationsMoment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)

Heart rate variability (lnRMSSD)

Trial Locations

Locations (1)

University of Trás-os-Montes e Alto-Douro

🇵🇹

Vila Real, Portugal

© Copyright 2025. All Rights Reserved by MedPath